Silence Therapeutics plc (OTCMKTS:SLNCF – Get Free Report)’s share price rose 3.2% on Thursday . The stock traded as high as $5.78 and last traded at $5.78. Approximately 100 shares were traded during mid-day trading, a decline of 94% from the average daily volume of 1,541 shares. The stock had previously closed at $5.60.
Silence Therapeutics Price Performance
The firm has a 50 day moving average of $6.14 and a two-hundred day moving average of $6.78.
About Silence Therapeutics
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of specific target genes in hematology, cardiovascular, and rare diseases. The company's mRNAi GalNAc Oligonucleotide Discovery platform consists of precision engineered product candidates designed to target specific disease-associated genes in the liver.
See Also
- Five stocks we like better than Silence Therapeutics
- What is a Stock Market Index and How Do You Use Them?
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Breakout Alert: Qualcomm Just Hit The Rally Button
- Best Stocks Under $5.00
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
